Physician

Ronald I Kaye, M.D.

According to 2025 Medicare claims, Ronald Kaye, M.D. (NPI: 1366538332) practices urology in the Utica-Rome, NY market, with the plurality of this provider's patient population coming from Oneida, NY. This provider's primary affiliated billing organization is ASSOCIATED MEDICAL PROFESSIONALS OF NY, PLLC (NPI: 1467659060; TIN: 208928235) and primary practice location at 13413-1102. Kaye is affiliated with the Bassett Accountable Care Partners, LLC (ACO ID: A2612), Trinity Health Integrated Care (ACO ID: A3454), Caravan Health ACO 50 LLC (ACO ID: A5160), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Kaye's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,349 traditional Medicare patients, billed 21,193 HCPCS/CPT codes, and received $348,543 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,371 prescription claims across 792 beneficiaries totaling $609,152 in drug costs, led by Erleada (Apalutamide). DME data shows 73 claims. Open Payments data shows 84 records totaling $1,779. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $468,744 and ending at $348,543. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $179,218 to $609,152. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $2,315 to $391.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,454	21,047	$468,744
2016	1,366	29,161	$477,450
2017	1,393	25,155	$462,342
2018	1,559	18,352	$351,794
2019	1,578	19,246	$339,256
2020	1,576	20,981	$371,861
2021	1,498	23,437	$378,020
2022	1,377	18,912	$463,114
2023	1,396	21,786	$600,533
2024	1,349	21,193	$348,543

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	587	2,431	$179,218
2016	616	2,749	$246,246
2017	653	2,941	$287,424
2018	680	3,198	$334,022
2019	692	3,228	$343,168
2020	727	3,314	$609,929
2021	737	3,286	$600,405
2022	748	3,228	$696,257
2023	826	3,782	$776,777
2024	792	3,371	$609,152

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	103	$5,443
2016	N/R	118	$17,682
2017	11	151	$17,925
2018	27	161	$20,777
2019	N/R	78	$10,698
2020	N/R	86	$23,150
2021	N/R	57	$24,413
2022	11	50	$27,557
2023	14	87	$37,129
2024	N/R	73	$39,253

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	402	467	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	250	280	$58
36415	Insertion of needle into vein for collection of blood sample	349	425	$9
51798	Ultrasound measurement of bladder capacity after voiding	338	380	$7
81003	Automated urinalysis test	751	1,062	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Erleada	Apalutamide	14	420	$184,015
Myrbetriq	Mirabegron	189	9,150	$142,319
Gemtesa	Vibegron	213	9,087	$138,887
Orgovyx	Relugolix	12	360	$29,487
Tamsulosin Hcl	Tamsulosin Hcl	1,172	89,929	$21,706

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	33	$22,146
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	40	$17,108

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	84	$1,779	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ronald I. Kaye, M.D.?

Tedicare shows public-source Medicare data for Ronald I. Kaye, M.D. (NPI 1366538332), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ronald I. Kaye, M.D. have ACO affiliation data?

Ronald I. Kaye, M.D. is shown with ACO affiliation data for Bassett Accountable Care Partners, LLC (MSSP, ACO ID A2612), Trinity Health Integrated Care (MSSP, ACO ID A3454), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Ronald I. Kaye, M.D.?

Ronald I. Kaye, M.D. is linked to ASSOCIATED MEDICAL PROFESSIONALS OF NY, PLLC (billing NPI 1467659060) in the available physician profile data.

Does Ronald I. Kaye, M.D. have Open Payments data?

Ronald I. Kaye, M.D. has 84 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.